Latest Lupus erythematosus Stories
Canadian researchers have linked initial use of oral contraceptives to an increased risk of lupus.
Mice from a strain that ordinarily develops systemic lupus erythematosus (SLE), but bred with a deficiency in receptor for the protein Interleukin 21, stayed healthy and exhibited none of the symptoms of the disease, researchers at The Jackson Laboratory and National Institutes of Health report.
ANN ARBOR, Mich., Jan.
SAN FRANCISCO, Oct.
Medarex has announced that its partner MedImmune has initiated a Phase IIa multi-dose clinical trial of MEDI-545 for the potential treatment of systemic lupus erythematosus. MEDI-545 is a fully human antibody generated by Medarex's UltiMAb Human Antibody Development System.
GAITHERSBURG, Md., Aug. 12 /PRNewswire/ -- MedImmune today announced that it has initiated enrollment in a Phase 2A trial with an investigational human monoclonal antibody (MAb) targeting interferon-alpha in patients with systemic lupus erythematosus (SLE or lupus).
Hadasit Bio-Holdings, a subsidiary of Hadasit, has announced that one of its portfolio companies, Verto, has successfully completed a human clinical trial of a device for treating patients who suffer from systemic lupus erythematosus.
Hadasit Bio-Holdings, (HBL) a subsidiary of Hadasit (the technology transfer company of the Hadassah - Hebrew University Medical Center), which is traded on the Tel Aviv Stock Exchange under the symbol HDST, announced today that one of its portfolio companies, Verto (in which it has a 75% stake), has successfully completed a human clinical trial of a device for treating patients who suffer from systemic lupus erythematosus.
Chinese scientists say a treatment using several drugs targeting various parts of the immune system helps patients with severe lupus involving the kidneys.